# Amgen Inc. (AMGN) — Q3-2009 Earnings Results

**Report date:** 2009-10-21 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2009

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 2.17%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.49 | N/A | +18.73% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings performance, particularly the EPS beat. They emphasized their commitment to shareholder value.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's strong EPS performance indicates effective cost management and operational efficiency. The stock's 2.17% increase reflects investor confidence in the company's ability to generate profits. However, the lack of revenue data and guidance may leave some investors cautious moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2009_